Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Arthritis and Rheumatism
|
May 27, 2006
Preventing and repairing vascular damage in scleroderma: should we focus beyond vasodilatation to recruitment of endothelial precursor cells?
Robert M Clancy
Arthritis and Rheumatism
|
February 28, 2009
When the levee doesn't break: a novel role of beta2-glycoprotein I to protect against congenital heart block
Robert M Clancy
Current Rheumatology Reports
|
March 8, 2017
ApoL1 and the Immune Response of Patients with Systemic Lupus Erythematosus
Ashira D Blazer, Robert M Clancy
Arthritis Research & Therapy
|
December 19, 2003
From antibody insult to fibrosis in neonatal lupus - the heart of the matter
Jill P Buyon, Robert M Clancy
Rheumatic Diseases Clinics of North America
|
June 1, 2005
Neonatal lupus: basic research and clinical perspectives
Jill P Buyon, Robert M Clancy
Rheumatic Diseases Clinics of North America
|
July 21, 2004
More to death than dying: apoptosis in the pathogenesis of SSA/Ro-SSB/La-associated congenital heart block
Robert M Clancy, Jill P Buyon
The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology
|
September 16, 2004
Autoimmune-associated congenital heart block: dissecting the cascade from immunologic insult to relentless fibrosis
Robert M Clancy, Jill P Buyon
Current Opinion in Rheumatology
|
September 10, 2003
Neonatal lupus syndromes
Jill P Buyon, Robert M Clancy
Autoimmunity Reviews
|
January 18, 2005
Autoantibody-associated congenital heart block: TGFbeta and the road to scar
Jill P Buyon, Robert M Clancy
Seminars in Arthritis and Rheumatism
|
December 13, 2003
Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach
Jill P Buyon, Robert M Clancy
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Arthritis and Rheumatism
|
May 27, 2006
Preventing and repairing vascular damage in scleroderma: should we focus beyond vasodilatation to recruitment of endothelial precursor cells?
Robert M Clancy
Arthritis and Rheumatism
|
February 28, 2009
When the levee doesn't break: a novel role of beta2-glycoprotein I to protect against congenital heart block
Robert M Clancy
Current Rheumatology Reports
|
March 8, 2017
ApoL1 and the Immune Response of Patients with Systemic Lupus Erythematosus
Ashira D Blazer, Robert M Clancy
Arthritis Research & Therapy
|
December 19, 2003
From antibody insult to fibrosis in neonatal lupus - the heart of the matter
Jill P Buyon, Robert M Clancy
Rheumatic Diseases Clinics of North America
|
June 1, 2005
Neonatal lupus: basic research and clinical perspectives
Jill P Buyon, Robert M Clancy
Rheumatic Diseases Clinics of North America
|
July 21, 2004
More to death than dying: apoptosis in the pathogenesis of SSA/Ro-SSB/La-associated congenital heart block
Robert M Clancy, Jill P Buyon
The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology
|
September 16, 2004
Autoimmune-associated congenital heart block: dissecting the cascade from immunologic insult to relentless fibrosis
Robert M Clancy, Jill P Buyon
Current Opinion in Rheumatology
|
September 10, 2003
Neonatal lupus syndromes
Jill P Buyon, Robert M Clancy
Autoimmunity Reviews
|
January 18, 2005
Autoantibody-associated congenital heart block: TGFbeta and the road to scar
Jill P Buyon, Robert M Clancy
Seminars in Arthritis and Rheumatism
|
December 13, 2003
Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach
Jill P Buyon, Robert M Clancy
Page
of 8